• Sonuç bulunamadı

A case of a free-floating ball thrombus in the left atrium after administration of streptokinase in a patient with early mitral valve replacement

N/A
N/A
Protected

Academic year: 2021

Share "A case of a free-floating ball thrombus in the left atrium after administration of streptokinase in a patient with early mitral valve replacement"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

177 Türk Göğüs Kalp Damar Cerrahisi Dergisi

Turkish Journal of Thoracic and Cardiovascular Surgery

doi: 10.5606/tgkdc.dergisi.2012.037 Turk Gogus Kalp Dama 2012;20(1):177-178

A case of a free-floating ball thrombus in the left atrium after administration

of streptokinase in a patient with early mitral valve replacement

Erken mitral kapak replasmanlı hastada streptokinaz uygulaması sonrası sol atriyumda

top şeklinde serbest yüzen trombüs olgusu

Halit Acet,1 Faruk Ertaş,2 Ferhat Özyurtlu3

1Department of Cardiology, Diyarbakır Training and Research Hospital, Diyarbakır; 2Department of Cardiology, Kızıltepe State Hospital, Mardin;

3Department of Cardiology, Diyarbakır State Hospital, Diyarbakır

Received: October 30, 2010 Accepted: August 10, 2011

Correspondence: Halit Acet, M.D. Diyarbakır Eğitim ve Araştırma Hastanesi Kardiyoloji Kliniği, 21100 Diyarbakır, Turkey. Tel: +90 505 - 319 01 83 e-mail: halitacet@gmail.com

This article presented a case of a free-floating ball thrombus in the left atrium after administration of streptokinase in a patient with early mitral valve replacement.

CASE REPORT

A 38-year-old female was admitted to our hospital with complaints of progressive dyspnea, orthopnea, and palpitations in the previous month (New York Heart Association Class IV). Four months previously she had undergone mitral valve replacement (MVR) with a St. Jude prosthesis (St. Jude Medical, Inc., St. Paul, MN, U.S.A.) for rheumatic mitral stenosis at another institution, but she was not taking warfarin when admitted to our facility. Her arterial blood pressure was 102/80 mmHg, and her pulse rate was 125 beats/minute with regular rhythm, but it could not be detected over the mitral valve area. Her whole blood count revealed leukocyte 12500 mm3,

hemoglobin 13 g/dl, hematocrit 41%, international normalized ratio (INR) 1.2, urea 32 mg/dl, and creatinine 1.3 mg/dl. Electrocardiography showed sinus rhythm with a heart rate of 125 beats/minute. On transthoracic echocardiography, a thrombus was observed over the mitral valve (Figure 1). Color

Doppler examinations demonstrated severe mitral stenosis (peak/mean gradient=36/22 mmHg and mitral valve area=0.8 cm2 calculated by the pressure half-time

method), (Figure 2) normal left ventricular dimensions, and systolic functions. We advised re-MVR and the removal of the thrombus, but she refused. Thus, we started streptokinase 250.000 intravenous

Editöre Mektup

Figure 1. Transesophageal echocardiography showing thrombus

(2)

Turk Gogus Kalp Dama

178

bolus followed by 100.000 units/hour for 24 hours. The patient’s general condition worsened, and she developed a peripheral thromboembolism in the right leg. Recurrent transthoracic and transesophageal echocardiography studies revealed a free-floating ball thrombus in the left atrium (LA) (Figure 3). The thrombus caused intermittent complete occlusion of the stenotic mitral valve. The patient underwent re-MVR surgery for emergency removal of the free-floating thrombus from the LA, and a histological examination proved that this diagnosis was correct.

A free-floating ball thrombus in the LA after MVR is a very rare[1] and dramatic finding seen

on echocardiography in patients with mitral valve disease.[2] When a ball thrombus is suspected on clinical

grounds, transthoracic echocardiography should be performed without any delay.[3] The presented case is

about MVR with a free-floating ball thrombus in the left atrium after the administration of streptokinase in a young patient.

Declaration of conflicting interests

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Funding

The authors received no financial support for the research and/or authorship of this article.

REFERENCES

1. Iida M, Shiono M, Shindou S, Akiyama K, Yagi S, Sezai Y. A case report of a left atrial ball thrombus at 16 years after mitral valve replacement. Nihon Kyobu Geka Gakkai Zasshi 1996;44:539-44. [Abstract]

2. Chen T, Lejemtel TH, Garcia J, Gordon GM, Spevack DM. Free-floating left atrial ball thrombus following mitral valve replacement. Echocardiography 2005;22:438-40.

3. Sanae T, Kazama S, Nie M, Miyoshi Y, Machii M, Ohara K, et al. Free-floating left atrial ball thrombus early after mitral valve replacement. Ann Thorac Cardiovasc Surg 2000;6:408-10.

Figure 2. Doppler examination showing severe mitral

Referanslar

Benzer Belgeler

In true FISP short axis sequences, pedunculated mass image derived from anterior and inferior wall is seen (arrow, lower left and lower right images). Figure

Bileaflet mechanic mitral valve was implanted without cross clamping the aorta in the beating heart conditions through the right thoracotomy.. and cardioplegia related

In conclusion, coronary artery embolism should be considered in the patients with acute myocardial infarction as a rare etiology especially when there is an associated risk factor

Aortic valve replacement using valve-in-valve procedure in a patient with left atrial appendage thrombus.. Sol atriyal apendikste trombüsü olan bir hastada kapak içine kapak işlemi

In this article, we present a successful valve-sparing aortic root replacement experience in a 19-year-old male patient of sinus valsalva aneurysm associated

case of mitral valve replacement via a transseptal approach in conjunction with aortic root replacement in a patient with dextrocardia and situs inversus in

We focus on the peri- and postoperative management of this rare coagulation disorder with a replacement therapy which included a recombinant activated coagulation factor VII

[3,4] According to many studies, elective cardiac surgery using CPB is generally considered to be contraindicated for patients with moderate to severe cirrhosis